We are motivated each day by the children we treat, and are working toward the day when all children with cancer are cured.
Philadelphia, Pennsylvania (PRWEB) June 08, 2011
Soupy for Loopy Foundation donated $50,000 to the Cancer Center at The Children’s Hospital of Philadelphia to fund research in neuroblastoma, a childhood cancer of the nervous system. The $50,000 gift will support two research projects aimed at developing more effective radiation treatments to kill neuroblastoma cells. The treatments, abbreviated as I-MIBG and MABG, selectively attack neuroblastoma tumors while minimizing injury to healthy tissues.
Both projects take advantage of the fact that radiation therapy is known to effectively attack neuroblastoma cells, even when the disease recurs after a patient relapses. One such treatment, already in use at Children’s Hospital because it has shown success against high-risk forms of neuroblastoma, uses 131I-meta-iodobenzylguanidine, abbreviated as 131I-MIBG, to deliver radiation to tumors. The researchers will improve MIBG therapy by discovering how to customize the optimum radiation dose for each individual child. The second project focuses on creating a new drug for neuroblastoma to eventually supplant I-MIBG. The new treatment, meta-[211At]astatobenzylguanidine (211At-MABG), contains radioactive particles carrying a stronger punch than those in MIBG. Its advantage is that in addition to attacking bulk tumor masses as I-MIBG does, it can also kill isolated tumor cells.
“Physician-scientists within the Center for Childhood Cancer Research at The Children’s Hospital of Philadelphia are fully committed to establishing better treatments to ultimately eradicate the pain and suffering from childhood cancer. We are motivated each day by the children we treat, and are working toward the day when all children with cancer are cured,” said John M. Maris, M.D., chief, Division of Oncology and director, Center for Childhood Cancer Research at The Children’s Hospital of Philadelphia. “We are truly grateful to Soupy for Loopy for supporting our neuroblastoma research efforts.”
Soupy for Loopy Foundation, an all-volunteer 501 (c)(3) charitable organization, was established in 2007 in memory of Laura Sypek who was affectionately called “Loopy” by her family. Diagnosed at age 2 with neuroblastoma, Laura loved to eat her mom’s tomato and macaroni soup, even during difficult chemotherapy treatments when most children have no appetite. Laura called it Soupy for Loopy and the name stuck. After battling cancer for most of her life, Laura died in 2006 at age 11. Soupy for Loopy Foundation is dedicated to raising funds to support doctors and hospitals working to advance neuroblastoma research. Funds raised from general donations, fundraising events and event sponsorships make grants like this possible.
“Laura had each and every clinical trial that she was eligible for but we ran out of options. NO parent should ever hear those words, ‘there is nothing left to try,’” said Debra Sypek, Laura’s mom, Officer and Board member of the Soupy for Loopy Foundation. “The Soupy for Loopy Foundation was established to fund research that will lead to clinical trials and more treatment options for children with neuroblastoma. There is not enough funding for pediatric cancer in general, let alone neuroblastoma.”
Neuroblastoma, a cancer of the peripheral nervous system, usually appears as a solid tumor in the chest or abdomen. It accounts for 7 percent of all childhood cancers, but because it is often aggressive, it causes 15 percent of all childhood cancer deaths.
To learn more about Laura Sypek, the Soupy for Loopy story or the Foundation, visit the website at http://www.soupyforloopy.org. SOUPY FOR LOOPY is a registered servicemark of Soupy for Loopy Foundation, Inc.
About the Cancer Center at The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia cares for more children with cancer than any other general pediatric hospital in the United States. Its large basic and clinical research programs are particularly strong in pediatric neuro-oncology, neuroblastoma, leukemia and lymphoma, and sarcomas. Of all pediatric institutions, Children's Hospital enrolls the most patients in national clinical trials, working in close collaboration with national organizations such as the Children's Oncology Group. Physicians at Children's Hospital have had pioneering roles in developing international standards for diagnosing and treating neuroblastoma, and in developing programs for survivors of childhood cancer.